LAPTM5 and metabolic dysfunction-associated steatotic liver disease: Moreover, the level of the lysosomal-associated protein transmembrane 5 is negatively correlated with the NAFLD activity score (NAS), and the hepatocyte-specific depletion of lysosomal-associated protein transmembrane 5 exacerbates MASH symptoms in mice17.